MAPT and Alzheimer disease: UA eliminates AD-related Tau hyperphosphorylation, reduces ROS production, decreases insoluble Aβ42 and Aβ40, and mitigates cognitive impairment in APP/PS1 and 3xTg AD mice [387-389].